MTBC Medical Transcription Billing Corp

CareCloud Shareholders Tentatively Approve Proposal to Increase Authorized Common Shares with Record Voter Turnout

CareCloud Shareholders Tentatively Approve Proposal to Increase Authorized Common Shares with Record Voter Turnout

SOMERSET, N.J., Jan. 24, 2025 (GLOBE NEWSWIRE) -- (the “Company” or “CareCloud”) (Nasdaq: CCLD, CCLDO, CCLDP), a leading provider of healthcare information technology and generative AI solutions for medical practices and health systems nationwide, today announced that shareholders have tentatively approved the proposal to increase the number of authorized common shares.

Approximately 10.4 million votes by proxy have been returned (the “votes”) in favor of increasing the authorized number of shares of common stock from 35 million to 85 million shares, marking one of the highest levels of positive votes in the Company’s history. The votes in favor represent over 80% of the total votes submitted.

“We truly appreciate the shareholders’ confidence in the Company’s direction, reflected in the nearly record-breaking number of ‘yes’ votes received by proxy,” said Stephen Snyder, Co-CEO of CareCloud.

The final vote count will be announced after the Common Stock Shareholder Special Meeting, scheduled for January 27, 2025.

About CareCloud

CareCloud brings disciplined innovation to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 40,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), business intelligence, patient experience management (PXM) and digital health at .

Follow CareCloud on , and .

SOURCE CareCloud

Company Contact:

Norman Roth

Interim Chief Financial Officer and Corporate Controller

CareCloud, Inc.

Investor Contact:

Stephen Snyder

Co-CEO

CareCloud, Inc.



EN
24/01/2025

Underlying

MTBCMedical Transcription Billing Corp

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Medical Transcription Billing Corp

 PRESS RELEASE
Free
MTBC Medical Transcr...

CareCloud Announces Preferred Stock Dividend Payments

CareCloud Announces Preferred Stock Dividend Payments SOMERSET, N.J., July 25, 2025 (GLOBE NEWSWIRE) -- (the “Company”) (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, announced today that its Board of Directors (the “Board”) has declared monthly cash dividends for its 8.75% Series A Cumulative Redeemable Perpetual Preferred Stock (“Series A Preferred Stock”) and its 8.75% Series B Cumulative Redeemable Perpetual Preferred Stock (“Series B Preferred Stock”) for July, August and September 2025. The ...

13h / 18m 1 EN
 PRESS RELEASE
Free
MTBC Medical Transcr...

CareCloud Launches AI-Driven, Fully Integrated Dermatology EHR to Stre...

CareCloud Launches AI-Driven, Fully Integrated Dermatology EHR to Streamline Workflows and Enhance Patient Care SOMERSET, N.J., July 17, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in healthcare technology and generative AI solutions for medical practices and health systems nationwide, today announced the launch of its fully integrated, AI-driven dermatology EHR, designed to streamline clinical workflows and collections, while enhancing patient engagement and improving financial outcomes for dermatology practices. "Our fully integrated, AI-dri...

July 17, 2025 1 EN
 PRESS RELEASE
Free
MTBC Medical Transcr...

CareCloud to Announce Second Quarter 2025 Results on August 5, 2025

CareCloud to Announce Second Quarter 2025 Results on August 5, 2025 SOMERSET, N.J., July 16, 2025 (GLOBE NEWSWIRE) --  (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions for medical practices and health systems nationwide, will release its financial results for the second quarter ended June 30, 2025 before the market opens on Tuesday, August 5, 2025. The Company will follow with a conference call for investors at 8:30 a.m. Eastern Time. The live webcast of the conference call and related presentation s...

July 16, 2025 1 EN
 PRESS RELEASE
Free
MTBC Medical Transcr...

CareCloud Emerges as a Top Gainer in Russell Microcap Index for Q2 202...

CareCloud Emerges as a Top Gainer in Russell Microcap Index for Q2 2025 with 70% Quarterly Increase SOMERSET, N.J., July 10, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-powered healthcare technology and revenue cycle management solutions, today announced that its common stock rose approximately 70% during the second quarter of 2025, making it among the top gainers in the Russell Microcap® Index for the period. The Company was officially added to the Russell Microcap Index effective June 30, 2025, following the annual recon...

July 10, 2025 1 EN
 PRESS RELEASE
Free
MTBC Medical Transcr...

CareCloud Joins Russell Microcap Index as Common Stock Price Rises 70%...

CareCloud Joins Russell Microcap Index as Common Stock Price Rises 70% During Q2 2025 SOMERSET, N.J., July 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-driven healthcare technology solutions for medical practices and health systems nationwide, today announced that it has been added to the Russell Microcap® Index, effective at the open of U.S. markets on June 30, 2025, as part of the Russell indexes’ annual reconstitution based on market capitalization, public float, and related criteria. The inclusion underscores growing...

July 2, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch